doi: 10.1128/AAC.01038-06.
Epub 2007 Jan 29.
Antifungal drug susceptibility profile of Pichia anomala isolates from patients presenting with nosocomial fungemia
Affiliations
- PMID: 17261632
- PMCID: PMC1855522
- DOI: 10.1128/AAC.01038-06
Item in Clipboard
Antifungal drug susceptibility profile of Pichia anomala isolates from patients presenting with nosocomial fungemia
Antimicrob Agents Chemother.
2007 Apr.
Abstract
In vitro susceptibility of 58 isolates of Pichia anomala to five antifungal drugs using two broth microdilution methods (CLSI and EUCAST) was analyzed. Low susceptibility to itraconazole was observed. Fluconazole, voriconazole, amphotericin B, and caspofungin showed good antifungal activity, although relatively high drug concentrations were necessary to inhibit the isolates.
Similar articles
-
[Profile of antifungal susceptibility of species of Candida isolated from hemocultures in a university hospital, Maracaibo, Venezuela].Rev Iberoam Micol. 2006 Jun;23(2):97-100. doi: 10.1016/s1130-1406(06)70022-5. Rev Iberoam Micol. 2006. PMID: 16854186 Spanish.
-
Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing and the Clinical Laboratory Standards Institute BMD method for non-Candida albicans and non-C. tropicalis bloodstream isolates from eleven tertiary hospitals in São Paulo state, Brazil.FEMS Yeast Res. 2012 Dec;12(8):890-6. doi: 10.1111/j.1567-1364.2012.00838.x. Epub 2012 Sep 14. FEMS Yeast Res. 2012. PMID: 22883021
-
In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.J Mycol Med. 2012 Sep;22(3):243-8. doi: 10.1016/j.mycmed.2012.06.002. Epub 2012 Aug 10. J Mycol Med. 2012. PMID: 23518082
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
-
Fluconazole-resistant Kodamaea ohmeri fungemia associated with cellulitis: case report and review of the literature.Int J Infect Dis. 2009 Nov;13(6):e493-7. doi: 10.1016/j.ijid.2009.02.003. Epub 2009 May 2. Int J Infect Dis. 2009. PMID: 19411182 Review.
Cited by
-
In vitro susceptibility of a large collection of Candida Strains against fluconazole and voriconazole by using the CLSI disk diffusion assay.Mycopathologia. 2011 Jun;171(6):411-6. doi: 10.1007/s11046-010-9387-1. Epub 2010 Dec 23. Mycopathologia. 2011. PMID: 21181497
-
In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.J Clin Microbiol. 2009 Oct;47(10):3170-7. doi: 10.1128/JCM.00942-09. Epub 2009 Aug 26. J Clin Microbiol. 2009. PMID: 19710283 Free PMC article.
-
Update on the genus Trichosporon.Mycopathologia. 2008 Sep;166(3):121-32. doi: 10.1007/s11046-008-9136-x. Epub 2008 Jun 21. Mycopathologia. 2008. PMID: 18568419 Review.
-
Wickerhamomyces anomalous: A Rare Cause of Fungemia Causing Febrile Neutropenia in Acute Lymphoblastic Leukemia.Case Rep Infect Dis. 2020 Dec 29;2020:8847853. doi: 10.1155/2020/8847853. eCollection 2020. Case Rep Infect Dis. 2020. PMID: 33457028 Free PMC article.
-
Rare Invasive Yeast Infections in Greek Neonates and Children, a Retrospective 12-Year Study.J Fungi (Basel). 2020 Sep 28;6(4):194. doi: 10.3390/jof6040194. J Fungi (Basel). 2020. PMID: 32998455 Free PMC article.
References
-
- Alter, S. J., and J. Farley. 1994. Development of Hansenula anomala infection in a child receiving fluconazole therapy. Pediatr. Infect. Dis. J. 13:158-159. - PubMed
-
- Aragão, P. A., I. C. Oshiro, E. I. Manrique, C. C. Gomes, L. L. Matsuo, C. Leone, M. L. Moretti-Branchini, and A. S. Levin. 2001. Pichia anomala outbreak in a nursery: exogenous source? Pediatr. Infect. Dis. J. 20:843-848. - PubMed
-
- Bakir, M., N. Cerikcioglu, A. Tirtir, S. Berrak, E. Ozek, and C. Canpolat. 2004. Pichia anomala fungaemia in immunocompromised children. Mycoses 47:231-235. - PubMed
-
- Barchiesi F., A. M Tortorano, L. F. Di Francesco, M. Cogliati, G. Scalise, and M. A. Viviani. 1999. In vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp. J. Antimicrob. Chemother. 43:295-299. - PubMed
-
- Barchiesi, F., A. M. Tortorano, L. F. Di Francesco, A. Rigoni, A. Giacometti, E. Spreghini, G. Scalise, and M. A. Viviani. 2005. Genotypic variation and antifungal susceptibilities of Candida pelliculosa clinical isolates. J. Med. Microbiol. 54:279-285. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
